• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC.(CRM-SYLMAR) DURATA STS OPTIM ACTIVE FIXATION, DF-4 CONNECTOR; PERMANENT DEFIBRILLATOR ELECTRODES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC.(CRM-SYLMAR) DURATA STS OPTIM ACTIVE FIXATION, DF-4 CONNECTOR; PERMANENT DEFIBRILLATOR ELECTRODES Back to Search Results
Model Number 7122Q/58
Device Problems Break (1069); Difficult to Fold, Unfold or Collapse (1254); Retraction Problem (1536); Low impedance (2285); Capturing Problem (2891); Device Sensing Problem (2917)
Patient Problem Cardiac Perforation (2513)
Event Type  Injury  
Event Description
Related manufacturer reference number: 2017865-2023-42638.It was reported that the patient received inappropriate high voltage (hv) therapy from their implantable cardioverter defibrillator due to incorrect interpretation of signals.During follow-up in clinic, it was noted that the patient's right ventricular lead exhibited high capture threshold and impedance.R-waves were noted to be diminished.It was elected to revise the lead.During lead revision, the helix of the lead failed to be retracted and extended.It was alleged that the lead had perforated the cardiac tissue, resulting in the helix issue.The lead was explanted and replaced.The patient was stable.
 
Event Description
It was reported that the patient received inappropriate high voltage (hv) therapy from their implantable cardioverter defibrillator due to incorrect interpretation of signals.During follow-up in clinic, it was noted that the patient's right ventricular lead exhibited high capture threshold and low pacing impedance.R-waves were noted to be diminished.It was elected to revise the lead.During lead revision, the helix of the lead failed to be retracted and extended.It was alleged that the lead had perforated the cardiac tissue, resulting in the helix issue.The lead was explanted and replaced.The patient was stable.
 
Manufacturer Narrative
The reported event of damaged helix was confirmed and the reported events of high capture threshold and impedance were not confirmed.As received, a complete lead was returned in one piece.Final analysis found the helix was retracted and clogged with blood/tissue.X-ray examination found the inner coil in the connector region was over torqued due to procedural damage.No further anomalies were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURATA STS OPTIM ACTIVE FIXATION, DF-4 CONNECTOR
Type of Device
PERMANENT DEFIBRILLATOR ELECTRODES
Manufacturer (Section D)
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
15900 valley view court
sylmar CA 91342
Manufacturer (Section G)
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
15900 valley view court
sylmar CA 91342
Manufacturer Contact
richard williamson
15900 valley view court
sylmar, CA 91342
MDR Report Key17716982
MDR Text Key323035930
Report Number2017865-2023-42639
Device Sequence Number1
Product Code NVY
UDI-Device Identifier05414734503174
UDI-Public05414734503174
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P950022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 10/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number7122Q/58
Device Lot NumberA000139415
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/22/2023
Initial Date FDA Received09/10/2023
Supplement Dates Manufacturer Received09/11/2023
09/22/2023
10/03/2023
Supplement Dates FDA Received09/13/2023
09/26/2023
10/11/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/11/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
TENDRIL.
Patient Outcome(s) Required Intervention;
Patient Age77 YR
Patient SexFemale
-
-